Please login to the form below

I have forgotten my password

Pfizer recalls depression drug in US

Wrong medicine found in bottle of Effexor XR

J&J gets EU green light for novel TB drug

Sirturo approved to treat multidrug resistant form of the disease

Novartis' dermatology plans advance with Xolair approval

Green light for use in chronic spontaneous urticaria

Diabetes awards programme launches

QiC Diabetes 2014 premiered at Diabetes UK conference

INC Research acquires Middle Eastern CRO

Purchase of MEK Consulting expands its geographic footprint

BMS' novel HIV drug clears phase II trial

Entry inhibitor BMS-660368 moves closer to first-in-class approval

Lilly/Boehringer's empagliflozin faces US approval delay

FDA cites manufacturing issues with the new diabetes drug

UDG buys KnowledgePoint360’s comms business

Deal is worth $144m

Edelman extends PR contract with Leo Pharma

Will continue to work together in Germany

Translational pharmacology: the key to ensuring safe and effective dosing

Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success

Use data responsibly

It’s imperative that opening up clinical trial data doesn’t compromise patient safety
Pharma’s four options for innovation

Only genuinely creative companies will profit from the future

More features

Eisai and Biogen partner on Alzheimer’s

Will co-develop two drug candidates
Generic for Lilly's Evista in US 'within a month'

Teva to launch copy of osteoporosis drug
NICE relents and backs Pfizer's Inlyta

Recommends drug to treat advanced kidney cancer on NHS in England
NHS promotes better drug understanding

‘My Medicines, My Health’ kicks off in north east England
KCR expanding into the UK and Germany

Contract research organisation registers two new entities
Teva launches first inhaled antipsychotic in US

Adasuve available for the treatment of agitation associated with schizophrenia or bipolar disorder
NICE: Alexion must justify Soliris' high cost

UK body unable to recommend ‘ultra-orphan’ drug

More news

Latest appointments

Stallergenes appoints Christian Chavy CEO

He will replace Roberto Gradnik at the end of this month
New VP for Merz North America

Gregory Bass to lead market access and reimbursement strategy
Vansen Pharma appoints new president and CEO

Ahmad Doroudian was CEO of Merus Labs International
Novasep appoints board chairman

CEO Michel Spagnol takes on dual role
AstraZeneca loses comms head

Neil McCrae to join UK’s Royal Mail

More appointments

Featured jobs

Senior Account Executive / Account Manager - Healthcare Advertising - London: £30000 - £39000 + Bonus + Benefits

Account Manager / (Senior) Analyst – Market Access: Up to £45,000 plus bonus

Director, Healthcare Public Affairs Consultancy

Account Manager - Healthcare PR/ Comms: £Competitive + excellent benefits

Senior Production Editor opportunity in Oxfordshire. Salary up to £65, 000.: Salary up to £65,000

Business Development Director: Competitive Salary Offered

Senior Copywriter – Advertising – London – £50k–£70K

Medical Writer – Medical Copy Writer – Healthcare Advertising - London

Account Director - Medical Education: Competitive + excellent benefits

Account Director - Medical Education - London / Manchester

Account Director- Healthcare: Highly Competitive Salary

Planning Director: Circa £100,000 with Extensive Package

Associate Director - Regulatory Affairs - Cambridgeshire: Negotiable

Group Account Director – Healthcare Advertising

Brand Manager - Oncology - South East: Excellent Basic, Bonus and Benefits

Client Director, Healthcare, Dublin: Competitive salary, plus benefits

SENIOR MEDICAL WRITER – UK – MEDICAL COMMUNICATIONS/ HEALTHCARE

Strategic/ Scientific Planner - RX – Healthcare Advertising – London

Account Associate: On application

Account Director – PR Healthcare: Excellent salary and package

Scientific Director - UK (London, North West & Oxfordshire)

Director of Strategy for Health

Senior Regulatory Affairs Associate - Clinical Trials - UK: Negotiable

Account Director - Medical Communications - Manchester: Negotiable

Marketing Manager UK & Ireland - Bagshot, Surrey: Circa £60,000 + benefits

Subscribe to our email news alerts

PMHub

Add my company

Health4Brands

At H4B, we are an energetic new team with fresh ideas, but we have over 275 years of combined experience...

Latest intelligence

Trust is key to online engagement: In social media it underlines the value of HCP networks...
Compulsory evaluation in France: French authorities will expect robust health economic cases to be made for some drugs...
Biosimilars: friend or foe for healthcare systems?: They present a significant opportunity in Europe, but achieving widespread acceptance and uptake of biosimilars is by no means a done deal...